Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Rituxan (rituximab) and cyclophosphamide are both used to treat various cancers, but they work differently and have different uses. Rituxan (rituximab) is a monoclonal antibody that targets specific immune cells called B cells, making it a targeted type of therapy called immunotherapy. It is given as an intravenous infusion and is used for blood cancers like non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune conditions like rheumatoid arthritis. Cyclophosphamide, on the other hand, is a form of chemotherapy. It's an alkylating agent that damages the DNA of cancer cells, leading to cell death. It can be taken orally or intravenously and is used for a broader range of cancers, including lymphomas, leukemias, and breast cancer, as well as nephrotic syndrome in children. Rituxan (rituximab) infusions can take several hours and may cause serious infusion-related reactions, while cyclophosphamide requires you to stay well-hydrated to prevent bladder and kidney problems. Both medications can weaken your immune system, but cyclophosphamide also has a higher risk of causing secondary cancers and fertility issues.
Cyclophosphamide is an anticancer medication used in the treatment of many types of adult and childhood cancers, as well as a certain type of kidney problem in children (nephrotic syndrome). It’s typically used in combination with other anticancer medications. Depending on the treatment regimen, cyclophosphamide can be taken as a pill by mouth or injected into the veins (intravenously or IV). This medication can cause serious bladder and kidney problems, so it’s important to stay well hydrated during treatment.